title: Medicare beneficiaries and free prescription drug samples: a national survey.
abstract: BACKGROUND
  New policies regulating physician/pharmaceutical company relationships propose to eliminate access to free prescription drug samples. Little is known about the prevalence of patient activity in requesting or receiving free prescription drug samples, or the characteristics of patients who access drug samples.
  
  
  OBJECTIVE
  To determine the prevalence of free sample access and to examine demographic, clinical, and insurance characteristics of Medicare beneficiaries who access free samples.
  
  
  METHODS
  Cross-sectional study.
  
  
  METHODS
  A national sample of 13,847 Medicare beneficiaries participating in the fall 2004 Medicare Current Beneficiary Survey.
  
  
  RESULTS
  Prevalence of free prescription drug sample access (self-reported request for or receipt of free drug samples) and the demographic, clinical, and insurance characteristics of Medicare beneficiaries who accessed drug samples. Overall, 48.3% (95% confidence of interval [CI]: 46.6%, 49.9%) of Medicare beneficiaries reported accessing free drug samples. Access was higher among beneficiaries reporting cost-related medication nonadherence compared to those without (77.7% (95% CI: 74.5%, 80.6%) vs 43.0% (95% CI: 41.4%, 44.7%)). Multivariable analysis revealed cost-related medication nonadherence (CRN) to have the strongest relationship with accessing drug samples (adjusted odds ratio [AOR] 4.43 [95% CI: 3.64, 5.39]). Compared to beneficiaries with generous drug benefits from Medicaid, beneficiaries who lacked prescription drug benefits were more likely to access drug samples (AOR 2.42 [95% CI: 2.06, 2.85]). Beneficiaries with drug coverage from employer-sponsored plans or partial coverage (Medicare HMO, self-purchased Medicare supplement, or state-sponsored low-income plans) were also more likely to access drug samples (AOR 2.02, 1.74, respectively). Having 2-3 or > or = 4 comorbidities (vs 0-1 comorbidities) also increased the likelihood of accessing drug samples (AOR 1.60 (95% CI: 1.44, 1.79) and 2.00 (95% CI: 1.74, 2.29).
  
  
  CONCLUSIONS
  Accessing free prescription drug samples is prevalent among many categories of beneficiaries, especially among individuals with cost-related medication nonadherence and poor health status. Policies restricting or prohibiting drug sample distribution may adversely impact access to medications among patients in high-risk groups.
authors: Meyers Primary Care Institute, Fallon Clinic Foundation, Worcester, MA, USA. jennifer.tjia@umassmed.edu
authors: Jennifer
authors: J
authors: Tjia
authors: Becky A
authors: BA
authors: Briesacher
authors: Stephen B
authors: SB
authors: Soumerai
authors: Marsha
authors: M
authors: Pierre-Jacques
authors: Fang
authors: F
authors: Zhang
authors: Dennis
authors: D
authors: Ross-Degnan
authors: Jerry H
authors: JH
authors: Gurwitz
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D003625:Data Collection; D016527:Drug Costs; D011307:Drug Prescriptions / Q000191:economics*; D005260:Female; D005102:Health Expenditures; D006801:Humans; D008297:Male; D040541:Marketing; D008489:Medical Indigency; D006278:Medicare; D008875:Middle Aged; D010817:Physician-Patient Relations; D010818:Practice Patterns, Physicians' / Q000191:economics* / Q000706:statistics & numerical data; D016312:Treatment Refusal / Q000706:statistics & numerical data; D014481:United States